ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
13F holders, Q1 2025
Institutional positions in ESSA Pharma Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −9 vs. Q4 2024
- Shares held
- 31.7M
- −1.15M (−3.5%) vs. Q4 2024
- Total value
- $50.1M
- −$8.71M (−14.8%) vs. Q4 2024
- New holders
- 3
- 7 more added
- Sold out
- 12
- 10 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 32 | $4.30M |
| Q2 2025 | 36 | $52.7M |
| Q1 2025 | 36 | $50.1M |
| Q4 2024 | 45 | $58.8M |
| Q3 2024 | 32 | $212.7M |
| Q2 2024 | 31 | $185.1M |
| Q1 2024 | 33 | $297.5M |
| Q4 2023 | 31 | $229.4M |
| Q3 2023 | 36 | $103.4M |
| Q2 2023 | 39 | $89.8M |
| Q1 2023 | 37 | $98.3M |
| Q4 2022 | 45 | $84.1M |
| Q3 2022 | 54 | $62.2M |
| Q2 2022 | 59 | $119.0M |
| Q1 2022 | 70 | $229.9M |
| Q4 2021 | 60 | $530.1M |
| Q3 2021 | 75 | $297.4M |
| Q2 2021 | 80 | $976.0M |
| Q1 2021 | 70 | $895.7M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding ESSA Pharma Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 8,748,629 | $13.8M | 0.56% | 00.0% | Unchanged |
| Tang Capital Management LLC | 4,300,000 | $6.79M | 0.38% | 00.0% | Unchanged |
| Morgan Stanley | 4,299,768 | $6.79M | 0.00% | +103,899+2.5% | Added |
| BML Capital Management, LLC | 4,221,546 | $6.67M | 5.40% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 2,262,026 | $3.57M | 0.28% | 00.0% | Unchanged |
| Opaleye Management Inc. | 2,209,998 | $3.49M | 0.78% | 00.0% | Unchanged |
| Pfizer Inc | 1,675,000 | $2.65M | 0.53% | 00.0% | Unchanged |
| Altium Capital Management LP | 1,050,369 | $1.66M | 4.82% | −377,631−26.4% | Reduced |
| Bank of America Corp | 698,268 | $1.10M | 0.00% | −114,042−14.0% | Reduced |
| Aldebaran Capital, LLC | 569,294 | $899.5K | 0.85% | +171,771+43.2% | Added |
| Two Sigma Investments, LP | 279,120 | $441.0K | 0.00% | +67,916+32.2% | Added |
| Two Sigma Advisers, LP | 276,100 | $436.2K | 0.00% | +193,500+234.3% | Added |
| BNP Paribas Arbitrage, SA | 235,401 | $371.9K | 0.00% | +70,806+43.0% | Added |
| DLD Asset Management, LP | 183,658 | $290.2K | 0.04% | +183,658 | New |
| JPMorgan Chase & Co | 164,875 | $260.5K | 0.00% | +164,854+785,019.0% | Added |
| Deuterium Capital Management, LLC | 110,412 | $174.5K | 0.39% | +110,412 | New |
| Citadel Advisors LLC | 82,123 | $129.8K | 0.00% | −76,918−48.4% | Reduced |
| Magnus Financial Group LLC | 55,206 | $87.2K | 0.01% | 00.0% | Unchanged |
| American Century Companies Inc | 46,373 | $73.3K | 0.00% | 00.0% | Unchanged |
| Lepercq De Neuflize Asset Management LLC | 31,700 | $50.1K | 0.05% | +1,500+5.0% | Added |
| Geode Capital Management, LLC | 26,858 | $42.4K | 0.00% | 00.0% | Unchanged |
| Shay Capital LLC | 24,631 | $38.9K | 0.01% | +24,631 | New |
| UBS Group AG | 23,608 | $37.3K | 0.00% | −72,006−75.3% | Reduced |
| Schonfeld Strategic Advisors LLC | 22,843 | $36.1K | 0.00% | −26,000−53.2% | Reduced |
| XTX Topco Ltd | 22,829 | $36.1K | 0.00% | −14,697−39.2% | Reduced |
| Group One Trading, L.P. | 21,118 | $33.4K | 0.00% | −15,230−41.9% | Reduced |
| Cubist Systematic Strategies, LLC | 14,115 | $22.3K | 0.00% | −12,172−46.3% | Reduced |
| BlackRock, Inc. | 7,074 | $11.2K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 6,000 | $9.48K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 4,050 | $6.40K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 3,688 | $5.83K | 0.00% | −253−6.4% | Reduced |
| CIBC Private Wealth Group, LLC | 2,500 | $3.67K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 900 | $1.40K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 817 | $1.00K | 0.00% | −101−11.0% | Reduced |
| Laurel Wealth Advisors LLC | 600 | $948 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 355 | $561 | 0.00% | 00.0% | Unchanged |
| RTW Investments, LP | 0 | $0 | 0.00% | −1,113,002−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −181,217−100.0% | Sold out |
| Vazirani Asset Management LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −45,810−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −17,704−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −16,700−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −15,943−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −15,687−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −14,525−100.0% | Sold out |
| 49 Wealth Management, LLC | 0 | $0 | 0.00% | −11,172−100.0% | Sold out |